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Birth order, maternal age, gestational age, birth weight, maternal smoking, and social class have all been associated 
with allergic rhinitis, eczema and asthma in childhood, but the consistency of independent effects of these exposures 
in relation to all of these allergic conditions has not been investigated. We have compared and contrasted the 
independent effects of these putative risk factors on parent-reported hayfever, eczema and wheeze by age 16 years 
and in the past 12 months at age 16 using data from the 1970 British birth cohort. 
The 1970 British birth cohort comprised all children born in England, Scotland and Wales in one week of April 
1970, and follow-up surveys at birth, 5, 10 and 16 years of age involved a cumulative total of 17 427 children. We 
have used data on over 6000 children with complete data at every stage. 
Social advantage was a risk factor common to each of wheeze at, and hayfever and eczema at and by age 16. Low 
birth order was an independent risk factor for eczema and hayfever at age 16, but not for wheeze. However, wheeze 
at age 16 was significantly increased in relation to maternal smoking, with a significant interaction such that the 
effect of smoking was greatest in those of high birth order and, in the absence of maternal smoking, low birth order 
was a risk factor for wheeze at age 16. 
Social advantage and low birth order appear to be the independently consistent determinants of atopic disease. 
Maternal smoking is an additional risk factor for wheeze, which applies primarily in low socioeconomic groups. 
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Introduction 
The occurrence of allergic disease is widely recognised to be 
the result of a complex interaction of genetic susceptibility 
and environmental influences, but the increasing prevalence 
of atopic sensitisation and the expression of the allergic 
phenotypes of asthma, eczema and hayfever over recent 
decades demonstrates the paramount importance of 
environmental aetiological factors. Although the exposures 
involved have not been identified, a number of putative 
early childhood risk factors have been identified for asthma, 
eczema and hayfever in isolation, and among these, low 
birth order has been associated with an increased risk of 
hayfever and eczema (l-3), low maternal age with an 
increased risk of wheezing (4-6) and pre-term birth with 
a reduced risk of eczema (3,7). Maternal smoking and 
low birth weight, which are established risk factors for 
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respiratory illness in infants, may also influence the occur- 
rence or severity of wheezing and asthma in older children 
(8-13). Prolonged and exclusive breast feeding may be 
associated with a reduction in eczema and food allergy in 
infancy (1416) but it is unclear whether this effect is 
sustained in later childhood (2,17,18). 
However, many of these exposures, are interrelated and it 
is not at all clear whether these risk factors are indepen- 
dently related only to specific allergic disease expression, or 
whether some or all of them apply to all diseases and may 
therefore be involved in an effect on the underlying risk of 
atopy. To determine which risk factors have the more 
important effects on all atopic disease, we have compared 
and contrasted the independent determinants of hayfever, 
eczema and wheeze by and at age 16 years using data from 
a national British Birth Cohort. 
Methods 
The 1970 British Birth Cohort (BCS70), which originated as 
a study of perinatal mortality, comprises all children born 
in England, Scotland and Wales in one week of April 1970. 
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TABLE 1. Distribution of sex, social advantage, and proportion with wheeze, eczema and hayfever at 
age 10 in those with and without complete data on all of the relevant factors 
Total Subset with Subset without 
column (%) complete data (%) complete data (%) 
n= 17427 n=6068 n=11359 
Sex Male 51.8 4x.7 53.5 
Female 48.2 51.3 46.5 
Social Index Most advantaged 9.6 10.4 8.8 
Advantaged 27.0 29.0 25.3 
Average 36.8 37.1 36.6 
Disadvantaged 15.3 14.0 16.4 
Most disadvantaged 11.3 9.4 12.9 
Wheeze at 10 age 7.7 7.3 7.9 
Eczema at 10 age 5.3 5.2 5.3 
Hayfever at age 10 7.6 7.6 7.6 
The base population at birth excluding stillbirths and 
neo-natal deaths comprised 16 163 children. The cohort 
was followed-up at ages 5, 10 and 16 years and was 
augmented by immigrants born during the allotted week to 
a cumulative total of 17 427 children. The background to 
this cohort and the methods of data collection have been 
described extensively elsewhere (19-21). 
Details of wheezing, eczema and hayfever were collected 
at each follow-up survey by parental interview conducted 
by health visitors. In those with a positive response at age 
16 to the question ‘Has the study teenager ever had any 
attacks of wheezing or whistling in the chest’, we defined an 
attack within the past 12 months as wheeze at age 16. A 
general health question in the same survey asked: ‘Has the 
study teenager suffered in the past 12 months from any of 
the following . .?’ which included hayfever or allergic 
rhinitis and eczematous rashes, and we defined positive 
responses as hayfever and eczema at age 16 respectively. 
Similar questions at ages 5 and 10 asked whether the child 
had ever had each of these conditions, and in those with 
complete information in each survey, a positive response at 
either of these ages or at 16 were defined as wheeze, 
hayfever and eczema by age 16. 
Details were collected by parental interview on a number 
of those factors previously implicated in relation to one or 
more of hayfever, eczema and wheeze, including maternal 
smoking in pregnancy, birth weight, gestational age, parity 
and maternal age, which were recorded by the midwife 
within 10 days of birth in the majority, duration of breast 
feeding ascertained at age 5 and current maternal smoking 
at age 16. A measure of social advantage (the Social Index) 
was derived from details of father’s occupational social 
class, parental education and housing information collected 
at age 5 (5). 
The independent and interactive effects of each of sex, 
maternal smoking in pregnancy and at age 16, birth weight, 
gestational age, parity, maternal age, breast feeding and the 
social index on wheeze, hayfever and eczema by and at age 
16 were assessed by multiple logistic regression in SPSS for 
Windows Version 7, and compared between diseases for 
consistency of effect. Explanatory factors were categorised 
where necessary before analysis, ensuring sufficient num- 
bers within strata. As the effects of in utero and current 
maternal cigarette smoke exposure, birth weight and gesta- 
tion were highly collinear, these factors were included in the 
multivariate model individually, and were subsequently 
included simultaneously where more than one exhibited a 
significant association, to assess the relative magnitude of 
their effects. A level of 5% was applied for global tests of 
significance and trend across all levels of each factor in the 
multivariate model. 
Results 
Details of hayfever, eczema and wheezing were available at 
ages 5 and 10 on at least 69% of the study population, but 
at age 16, the response rate was lower at 55% for wheeze 
and 54% for hayfever and eczema at age 16. Complete data 
on each of sex, social advantage, breast feeding, maternal 
age, parity, maternal smoking, and birth weight, and on 
hayfever and eczema at age 16 were available in 7162, 
wheeze at 16 in 7249, and hayfever, eczema and wheeze by 
age 16 in 6281, 6352 and 6596 children respectively. 
Females and the socially advantaged tended to be over- 
represented among the 6068 with complete data on all of 
these variables (Table 1). The response rate at age 16 was 
however similar in those with and without symptoms at 
previous surveys. 
Most wheeze and eczema by age 16 was first reported by 
the follow-up survey at age 5 and was no longer current at 
age 16. Wheeze at and by age 16 was reported in 6.5% and 
34.8% respectively, and eczema at and by age 16 in 6.4% 
and 19.1% respectively. On the contrary, the vast majority 
of hayfever by age 16 was first reported in the survey at age 
16 and was current at this age; hayfever at and by 16 was 
reported in 23.3% and 26.2% respectively. 
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TABLE 2. Mutually adjusted odds ratios for the effects of sex, social advantage, maternal smoking, low birth weight, 
gestational age, breast feeding, maternal age, and parity on hayfever, eczema and wheeze by age 16 
Hayfever by age 16 Eczema by age 16 Wheeze by age 16 
Total in the main model 
Sex 
Social advantage 
Breast fed (months) 
Maternal age (years) 
Parity 
Maternal smoking in pregnancy 
Current maternal smoking 
Birth weight (kg) 
Gestational age (weeks) 
Male 
Female 
Most disadvantaged 
Disadvantaged 
Average 
Advantaged 
Most advantaged 
Never 
<I 
1-3 
23 
120 
20-24 
25-29 
30-34 
35-39 
40+ 
First born 
2 
3 
4 
5+ 
None 
l&4 
5-14 
15+ 
Never 
14 
5-14 
15+ 
>3 
2.5-3.0 
2-2.5 
12 
>39 
37-39 
35-37 
<35 
n=6281 
1 * 
0.85 (0.76-0.95) 
1 *t 
1.05 (08-1.37) 
1.19 (0.95-1.49) 
1.35 (1.06-1.71) 
1.48 (1.12-1.96) 
1 
1.13 (0.96-1.32) 
1.14 (0.9551.38) 
1.00 (0.8331.21) 
1 t 
1.08 (0.8661.36) 
1.27 (1.00-1.63) 
1.36 (1.03-1.80) 
1.23 (0.87-1.73) 
1.56 (0.93-2.60) 
1 *t 
0.75 (0.65-0.86) 
0.60 (0.50-0.73) 
0.48 (0.37-0.64) 
0.47 (0.34-0.66) 
1 *t 
1.09 (0.88-1.36) 
0.94 (0.81-1.09) 
0.77 (0.63-0.94) 
1 
0.70 (0.4551.09) 
1.11 (09-1.37) 
0.87 (0.74-1.03) 
1 
1.09 (0.95-1.26) 
0.95 (0.72-1.24) 
0.86 (0.53-1.41) 
1 
1.06 (0.89-1.26) 
0.95 (0.66-1.38) 
0.91 (0.53-1.54) 
n=6352 
1 
1.08 (0.95-l .22) 
1 *A 
1.07 (08l1.42) 
1.00 (0.7771.28) 
1.44 (1.11-1.87) 
1.62 (1.20-2.18) 
1 t 
0.99 (0.83-1.19) 
1.12 (0.91-1.37) 
1.26 (1.04-1.53) 
1 
1.13 (0.87-1.47) 
1.14 (0.86-1.51) 
1.15 (0.84-1.58) 
1.07 (0.73-1.58) 
0.44 (0.20-0.96) 
1 .!. 
0.95 (0.82-1.11)’ 
0.92 (0.75-1.13) 
0.77 (0.57-1.04) 
0.73 (0.50-1.06) 
1 
1.06 (0.83-1.35) 
0.91 (0.78-1.08) 
0.96 (0.78-1.18) 
1 
0.93 (0.59-1.46) 
1.02 (0.81-1.29) 
1.02 (0.85-l .22) 
1 * 
1.21 (1.0441.42) 
0.72 (0.52-1.01) 
0.60 (0.32-1.14) 
1 
0.83 (0.6881.63) 
0.89 (0.57-1.36) 
0.89 (0.4991.63) 
n=6596 
1 
0.72 (0.6550.80) 
1 
0.91 (0.73-1.13) 
0.91 (0.75-1.10) 
0.92 (0.75-1.12) 
0.84 (0.66-1.07) 
1 t 
0.94 (0.81-1.09) 
0.92 (0.77-1.09) 
0.84 (0.71-1.00) 
1 
1.03 (0.84-l .27) 
1.11 (0.8991.39) 
1.16 (09-1.49) 
1.29 (0.95-l .74) 
0.88 (0.5551.40) 
1 
0.98 (0.86-1.11) 
0.95 (0.80-1.12) 
0.76 (0.60-0.97) 
0.86 (0.65-1.14) 
1 * 
1.25 (1.02-1.53) 
1.23 (1.08-l .40) 
1.35 (1.15-1.59) 
1 * 
1.42 (0.99-2.03) 
1.46 (1.21-1.75) 
1.41 (1.22-1.62) 
1 *t 
1.20 (1.05-1.36) 
0.98 (0.77-1.24) 
1.41 (0.942.12) 
1 
0.99 (0.84-1.17) 
0.95 (0.6991.32) 
1.13 (0.72-1.78) 
“PcO.05 for chi-squared test of independence across all categories of the variable. 
tptCd ~0.05 for chi-squared test for trend across all categories of the variable. 
Social advantage was the only risk factor that was 
statistically significantly related to all of the conditions 
hayfever, eczema and wheeze either at or by age 16 [Tables 
2 and 3, Fig. l(a)], such that in the most relative to the least 
advantaged, the risk of hayfever at and by age 16 was 
increased (adjusted OR (95% CI) 1.68 (1.28-2.19) and 1.48 
(1.12-1.96) respectively), as was the risk of eczema by age 
16 (adjusted OR (95% CI) 1.62 (1.20-2.18)) and the risk of 
wheeze at age 16 also increased with increasing social 
advantage (Ptrend= 0.03). Eczema at age 16 was also com- 
monest in the most advantaged, but with a weaker trend 
with increasing disadvantage. Wheeze by age 16 exhibited a 
different relationship with social index, however, with a 
non-significant trend towards an increased risk in the more 
disadvantaged. 
Birth order was also an independent determinant of the 
risk of both hayfever and eczema by and at age 16, such 
that the risk of hayfever at and by age 16 were significantly 
increased in first born children relative to those of fifth or 
greater birth order (adjusted OR 2.08 (1.49-2.90) and 2.12 
(1.51-2.98)) and there were significant trends for the risk of 
eczema by and at age 16 also to be increased in first born 
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TABLE 3. Mutually adjusted odds ratios for the effects of sex, social advantage, maternal smoking, low birth weight, 
gestational age, breast feeding, maternal age, and parity on hayfever, eczema and wheeze at age 16 
Hayfever at age 16 Eczema at age 16 Wheeze at age 16 
Total in the main model 
Sex Male 
Female 
Social advantage Most disadvantaged 
Disadvantaged 
Average 
Advantaged 
Most advantaged 
Breast fed (months) Never 
<l 
l-3 
>3 
Maternal age (years) <20 
20-24 
25-29 
30-34 
35-39 
40+ 
Parity First born 
2 
3 
4 
5+ 
Maternal smoking in pregnancy None 
l-4 
5-14 
15+ 
Current maternal smoking Never 
14 
5514 
15+ 
Birth weight (kg) 23 
2.5-3.0 
2-2.5 
<2 
Gestational age (weeks) >39 
37-39 
35-37 
<35 
n=7162 
1 * 
0.85 (0.7660.95) 
1 *A 
1.10 (0.8551.41) 
1.20 (0.96-1.50) 
1.41 (1.11-1.77) 
1.68 (1.28-2.19) 
1 
1.14 (0.98-1.28) 
1.14 (0.95-1.37) 
1.03 (0.86-1.23) 
1 ‘r 
1.22 (0.9881.53) 
1.35 (1.06-1.71) 
153 (1.17-2.01) 
1.35 (0.9661.88) 
1.75 (1.07-2.88) 
1 *t 
0.74 (0.65-0.85) 
0.63 (0.52-0.76) 
0.50 (0.3880.65) 
0.48 (0.35-0.67) 
1 .10 (0.89-1.35; 
0.90 (0.95-1.37) 
0.78 (0.8661.23) 
1 t 
0.69 (0.45-1.05) 
1.05 (0.87-1.28) 
0.78 (0.67-0.92) 
1 
1.06 (0.92-1.22) 
1.01 (0.78-1.30) 
0.66 (0.40&1.09) 
1 
1.03 (0.8661.24) 
0.88 (06l1.27) 
0.84 (0.50-1.41) 
n=7162 
1 * 
1.72 (1.41-2.10) 
1 * 
0.94 (0.63-1.40) 
0.7 1 (050-l .03) 
I.02 (0.71-1.49) 
1.04 (0.67-1.62) 
1 
0.89 (0.6771.17) 
1.21 (0.90-1.64) 
0.98 (0.72-1.48) 
1 
1.03 (0.69-1.53) 
1.34 (0.88-2.03) 
1.27 (0.7992.03) 
1.15 (0.6442.07) 
0.67 (0.22-1.99) 
1 t 
0.78 (0.62-0.99) 
0.69 (0.50-0.96) 
0.68 (0.44-1.07) 
0.70 (0.41-1.20) 
1 
0.89 (0.60-1.31) 
0.80 (0.62-1.05) 
1.10 (0.81-1.48) 
1 
0.52 (0.21-1.18) 
1.13 (0.80-1.61) 
1.27 (0.98-1.66) 
1 
1.18 (0.94-1.49) 
0.75 (0.45-1.24) 
0.68 (0.27-1.69) 
1 
0.86 (0.62-1.18) 
0.44 (0.18-1.07) 
0.85 (0.34-2.13) 
n = 7249 
1 
0.94 (0.78-1.14) 
1 t 
1.07 (0.71-1.61) 
1.06 (0.74-1.52) 
1.38 (0.94-2.01) 
1.43 (0.91-2.24) 
1 
0.82 (0.62-0.94) 
1.11 (0.82-1.50) 
0.85 (06L1.17) 
1 t 
0.75 (0.53-1.06) 
0.70 (0.48-1.02) 
0.68 (0.44-1.06) 
0.54 (0.30-0.95) 
0.43 (0.16-1.14) 
1 
0.92 (0.7331.17) 
1.08 (0.79-1.47) 
0.99 (0.64-1.53) 
1.07 (0.63-1.83) 
1 * 
1.18 (0.83-1.68) 
0.93 (0.72-1.20) 
1.47 (1.11-1.94) 
1 
1.31 (0.71-2.41) 
1.30 (0.94-1.80) 
1.21 (0.94-1.57) 
1 *t 
1.43 (1.15-1.78) 
1.06 (0.6881.65) 
1.84 (0.99-3.40) 
1 
0.90 (0.66-1.23) 
0.75 (0.38-1.48) 
1.11 (0.51-2.42) 
*P<O.O5 for chi-squared test of independence across all categories of the variable. 
TP,,,,,<O.O5 for chi-squared test for trend across all categories of the variable. 
relative to subsequent children [Fig. l(b)]. There was odds ratio of 1.26 (95% CI 1.041.53) in those breast fed 
little evidence of a corresponding effect of birth order on for 3 months or longer relative to those exclusively bottle 
wheezing either at or by age 16. fed and wheezing by age 16 reduced by an odds ratio of 
The effects of the remaining factors were less consistent 0.84 (95% CI 0.71-1.00). Wheeze at age 16 and hayfever 
across the three conditions. Eczema at age 16 was more by or at age 16 were each significantly linearly related to 
common in females, hayfever at and by age 16 and maternal age, but again the trends were in opposite 
wheeze by age 16 more common in males, and there was a directions in the two conditions such that the risk of 
similar risk of eczema by age 16 and wheeze at age 16 wheeze was increased two-fold in children of mothers 
in males and females. The risk of eczema and wheeze by under age 20 relative to mothers over age 40, whilst the 
age 16 were each linearly related to the duration of risk of hayfever was almost halved in these children 
breast feeding, but such that eczema was increased by an [Fig. l(c)]. 
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FIG. 1. Comparison of the multivariate effects of Social Index (a), birth order (b), maternal age (c), and maternal smoking 
(d) on hayfever (- - -, n=6281) and eczema (- - -, n=6352) by age 16 and wheeze (-, n=7249) at age 16. 
Wheezing at and by age 16 were each independently 
increased in relation to smoking in pregnancy, though only 
the risk of wheezing by age 16 was strongly dose related to 
the level of maternal cigarette consumption. Wheezing by 
and at age 16 were also significantly increased in relation to 
low birth weight, and though birth weight and maternal 
smoking in pregnancy were strongly correlated, the effects 
of each remained significant after mutual adjustment, such 
that wheeze by and at age 16 were independently increased 
in relation to maternal smoking at levels in excess of 15 
cigarettes/day during pregnancy (adjusted OR (95% CI) 
1.33 (1.13-1.56) and 1.41 (1.07-1.87)) and in those with a 
birth weight less than 3 kg (adjusted OR (95% CI) 1.14 
(1.01-1.29) and 1.35 (1.10-1.67)). On the contrary, the risk 
of hayfever by and at age 16 reduced linearly with increas- 
ing maternal cigarette consumption [Fig. l(d)], either in 
pregnancy or at current levels, whilst eczema was unrelated 
to maternal smoking at either stage, but significantly less 
common by age 16 in those of low birth weight. There was 
no corresponding effect of pre-term birth on any of these 
outcomes. 
Interactions between the effects of smoking in pregnancy, 
birth weight, birth order, and maternal age, fitted to explore 
further the differential effects of these variables on wheeze 
relative to hayfever and eczema, revealed a significant 
interaction between the effects of maternal smoking in 
pregnancy and parity on the occurrence of wheezing at age 
16 (P=O.O09). The form of this interaction was such that in 
children of non-smoking mothers, the risk of wheezing 
reduced linearly with increasing birth order (first born=low 
birth order), in a similar manner to that described for 
eczema by, and hayfever by or at age 16, whilst an inverse 
relationship was apparent in children of smoking mothers 
(Fig. 2). When cigarette consumption was categorised into 
low (< 15 cigs/day) and high (15 + cigs/day) levels in order to 
provide sufficient numbers within the birth order categories, 
o.6/ 
0.4 
x 
d 0.2 
I 
-2 
% 0 
m 
3 
Et -0.2 
2 
-0.4 
-0.6 ' 
1 
I I 
2 3 4+ 
Birth order 
FIG. 2. Interaction between the effects of two levels of 
smoking and birth order on wheeze at age 16. -, Non- 
smoker; - - -, smoker c 15 cigs/day; - - - -, smoker > 15 
cigsiday. *With respect to first-born children of non- 
smoking mothers. 
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it was apparent that in all levels of birth order the risk of 
wheezing was increased in relation to high levels of mater- 
nal smoking, whilst in relation to low levels of smoke 
exposure the risk of wheeze tended to increase with increas- 
ing birth order. The nature of the interaction also revealed 
a stronger dose-response relationship between levels of 
cigarette consumption and the risk of wheezing in those of 
high birth order. 
Discussion 
This study has demonstrated that of all of the various risk 
factors associated with allergic disease, high social class and 
low birth order are the factors consistently associated with 
allergic phenotypes. The social class effect was consistent in 
its own right, whilst the effect of birth order on adolescent 
wheezing was apparent after allowing for effects of mater- 
nal smoking. The independent effect of smoking was, 
however, if anything to reduce the risk of other allergic 
diseases. Significant associations with either hayfever, 
eczema or wheeze by or at age 16 were found for each of 
gender, birth weight, mode of infant feeding, and maternal 
age, but the significance and direction of the effects of these 
factors were not consistent between diseases. 
These results are based on a birth cohort population 
which in its original form was highly representative of the 
general population of children. However, the 1970 cohort 
was subject to a considerable loss-to-follow-up at age 16, 
such that complete data for this study were available for 
between 36% and 42%, dependent on outcome, of the base 
population. We know that males and those in the less 
advantaged groups tended to be underrepresented, which 
may have impacted on our prevalence estimates and is a 
potential limitation in the generalisability of our findings. 
Bias resulting from the low response may also have contrib- 
uted to our aetiological findings, but there was no indica- 
tion that response rates were different for symptomatic and 
asymptomatic children so our aetiological comparisons are 
likely to be relatively unaffected. 
Our findings implicate low birth order and social advan- 
tage as the strongest markers of those environmental 
factors which influence the development of atopy. Differ- 
ential parental awareness or recall of allergic symptoms 
might have tended to strengthen the association between 
these factors and parentally reported disease in our study, 
and we had no objective measures of atopy for this cohort 
to support this supposition. Nevertheless, this result is 
broadly consistent with the outcome of a recent follow-up 
study of the 1958 British birth cohort, in which the number 
of older siblings and higher socioeconomic status in 
childhood were the strongest determinants of positivity to 
skin prick tests, performed in a sample of the cohort at age 
35 (23). In the 1958 cohort, hayfever was also reduced in 
relation to the number of younger siblings in the household, 
but this effect was much weaker than the influence of the 
number of older siblings (17), and this contrast was also 
apparent in the 1970 cohort (data not shown). An increased 
risk of eczema and hayfever in relation to affluence and 
small family size has been reported in a number of different 
populations (2,3,24), but this association has been less 
consistently observed in relation to asthma (25). Our results 
in relation to wheeze at 16 suggest that this may be 
attributable to the impact of maternal smoking, which 
modified the effect of birth order such that a negative 
association between wheezing and birth order was only 
apparent in the absence of maternal smoking. 
Wheezing by age 16 alone bore a substantially different 
relationship with socioeconomic status and birth order. We 
have previously demonstrated in this cohort that the 
majority of wheezing in childhood occurs and resolves in 
the first few years of life, and confirmed that the primary 
risk factors for early transient wheezing are maternal smok- 
ing in pregnancy and low birth weight, with a tendency also 
to an increased risk in non-breast fed infants (26). That the 
same three factors were also the major determinants of 
wheezing at any time from birth to age 16 in the current 
study was in keeping with our previous results. In the light 
of evidence that in utero cigarette smoke exposure and low 
birth weight are associated with reduced lung function at 
birth (27-29), and that this predisposes to an increased risk 
of wheezing as a response to viral infections (30), which 
may in turn be more likely in the absence of breast 
feeding (31,32), our findings suggest that the majority of 
wheezing in early childhood is the expression of a disease 
either unrelated to, or less strongly related to, allergic 
mechanisms. 
Whereas maternal smoking is firmly established as a risk 
factor for respiratory illness in early life, weaker effects of 
this exposure have been reported in relation to wheezing in 
the older child (33,34). The effect of maternal smoking on 
wheeze at age 16 in these analyses did not appear to be due 
to confounding by effects of personal smoking, since with 
mutual adjustment, maternal smoking, but not personal 
smoking as reported by the teenager at age 16, significantly 
increased the risk of wheeze at age 16 (details not reported). 
It was more difficult to distinguish between the potentially 
separate effects of passive exposure to cigarette smoke 
before and after birth, since the majority of mothers 
smoked at similar levels throughout the follow-up of the 
cohort and those who changed smoking habit tended to be 
the more advantaged and better educated and were there- 
fore implicitly different from those who did not. Neverthe- 
less, only maternal smoking in pregnancy was significantly 
associated with current wheezing at age 16, and given that 
in utero exposure to cigarette smoke and low birth weight, 
which is itself linked to smoking in pregnancy, may be 
associated with a reduced lung function, not only at birth 
(27-29), but also in later childhood (8,35-39), and even in 
older adult life (40), one possibility is that in utero exposure 
to cigarette smoke results in a permanent detriment in 
airway calibre and a concomitant increase in the suscepti- 
bility to wheezing, potentially in response to a number of 
provoking stimuli. The increase in risk of current wheeze 
with increased birth order in those exposed to cigarette 
smoke might, by this argument, be attributable to increased 
exposure to respiratory viruses as the provoking factor. 
Alternatively, children of small families and better social 
circumstances may be protected from the detrimental 
effects of cigarette smoke, either directly by the parent’s 
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smoking behaviour or indirectly through factors such as 
diet. Whatever the factors underlying the interaction 
between the effects of birth order and maternal smoking, 
these results are in line with emerging evidence that in 
addition to the two widely recognised wheezing syndromes 
in children, early transient wheezing associated with viral 
infection and persistent atopic wheezing, there may be a 
further disease entity, persistent episodic viral wheezing 
(41). Our data suggest that smoking in pregnancy, 
especially at high levels, may be involved in the aetiology of 
this condition, and that this is the more likely pathology of 
adolescent wheezing in those of high birth order or low 
socioeconomic status. 
However, we found no evidence to support the supposi- 
tion that maternal smoking contributes to the development 
of atopy. On the contrary, hayfever was significantly less 
common in relation to high levels of maternal smoking. A 
tendency for atopic mothers to avoid smoking could have 
contributed to this negative association, but details of 
maternal (and paternal) asthma, eczema and hayfever were 
collected in the first follow-up survey of this cohort, and the 
effect of maternal smoking on hayfever was little changed 
and remained significant in an analysis restricted to mothers 
with none of these conditions (adjusted OR for hayfever at 
age 16 in relation to 15+cigs/day=0.77, 95% CI 0.61-0.96). 
Several studies have now observed inverse associations 
between maternal smoking and skin prick test positivity 
(11X442), and it is conceivable that maternal smoke 
exposure might actually protect against the development of 
atopy. 
In terms of an explanation for the rising prevalence of all 
of these allergic conditions, we have previously looked at 
whether changes in birth order or smoking could be import- 
ant by analysing cross-cohort differences occurring in the 
12 years between the 1958 and 1970 British birth cohorts. 
We found that although these factors were associated with 
increased risk of disease within the cohorts, neither of them 
explained much of the increase in prevalence (20,21). These 
findings suggest therefore that the rising prevalence of 
allergic disease must relate to other factors. Social advan- 
tage, or rather the affluent lifestyle associated with social 
advantage, therefore emerges as a strong candidate to 
explain the increase, since this was the most consistent risk 
factor for all allergic disease identified in this study, and is 
a factor which has clearly increased longitudinally across 
society, albeit without being easily measured in objective 
terms. This study therefore highlights the need to identify 
factors associated with improved living standards, and 
possibly in particular those disproportionately linked with 
the number of early childhood contacts, to elucidate on the 
underlying cause of the recent increase in atopic disease. 
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